Post IVIG Medication in Children With Immune Thrombocytopenia

Clinical trial NCT04741139 · UNKNOWN

Trial details

NCT number: NCT04741139
Sponsor: Baylor College of Medicine
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2021-09-02
Primary completion: 2022-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.